BIO.News Newsletter

CDC has noticed an increase in “extensively drug-resistant” Shigella infections—the latest evidence of the growing threat of AMR. Plus, the U.S. Chamber released the 11th International IP Index with a warning about the impact of threats to IP on our ability to fight the next pandemic. (516 words, 2 minutes, 34 seconds)

CMS reaffirms its decision on coverage of breakthrough Alzheimer’s drugs—here’s what they said. Plus, we popped into USDA’s Agricultural Outlook Forum yesterday where we heard Secretary Vilsack’s views on SAF and what the administration’s thinking about Mexico. (539 words, 2 minutes, 41 seconds)

With the Farm Bill up for reauthorization this year, a food, agriculture, and biotech industry coalition (including BIO) released policy recommendations. Plus, we look at what’s happening with the biosimilars market in 2023. (579 words, 2 minutes, 53 seconds)

There has been more positive COVID news in recent weeks about the impact of boosters and therapeutics—but we still have work to do on long COVID. (558 words, 2 minutes, 47 seconds)

Back to work with exciting news about biotech trees and insights into how Medicare may choose the first ten drugs for price controls—plus, a Bio.News exclusive about how we can advance R&D in women’s health. (735 words, 3 minutes, 40 seconds)

Happy Friday. We recap yesterday’s hearing on the Pharmacy Benefit Manager Transparency Act and what BIO says about it—and look at why 2023 could be the year of RSV (in a good way). (610 words, 3 minutes, 3 seconds)Good Day BIO will take a break on Monday, February 20 for Presidents’ Day. We’ll return to our regular publishing schedule on Tuesday, February 21. In the meantime, keep an eye on Bio.News for breaking news.

On Innovation Day, we look at recent biotech breakthroughs to make animals healthier, haircare cleaner, and even houseplants more efficient—and the health impacts if we don’t advance these innovations. (576 words, 2 minutes, 52 seconds)

HHS will test three pilot payment models—here’s BIO’s take. Plus, reactions to Mexico’s modified biotech corn ban and what you need to know about long COVID symptoms and R&D. (699 words, 3 minutes, 29 seconds)

Happy Valentine’s Day. We have a new development on Mexico’s corn ban, insights on why we need to update vaccine policy, and a lot more news. (667 words, 3 minutes, 20 seconds)

The U.S. told Mexico it has until tomorrow to explain the science behind the biotech corn ban—something BIO’s long called for. Plus, we have an exclusive look at what to expect in the state legislatures in 2023. (Hint: A lot of vaccine-related bills.) (642 words, 3 minutes, 12 seconds)